会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 23. 发明授权
    • Method for determining percent platelet aggregation
    • 确定血小板聚集百分比的方法
    • US07595169B2
    • 2009-09-29
    • US11411239
    • 2006-04-24
    • Lisa SwaimDennis Durbin
    • Lisa SwaimDennis Durbin
    • C12Q1/56
    • C12Q1/56G01N33/86
    • A method for obtaining a percent aggregation or inhibition of platelets resulting from anti-platelet using a single blood sample is achieved. An assay device is provided. The assay device has multiple channels, each coupled to a common introduction port. A first platelet activator is sensitive to activation pathway targeted by the anti-platelet drug. A second platelet activator is insensitive to the activation pathway targeted by the anti-platelet drug. An anti-coagulated sample is introduced simultaneously to the first and second channels. A level of platelet aggregation is simultaneously made in both channels.
    • 实现了使用单一血液样品获得由抗血小板产生的血小板聚集或抑制百分比的方法。 提供测定装置。 测定装置具有多个通道,每个通道耦合到公共引入端口。 第一种血小板活化剂对抗血小板药物靶向的活化途径敏感。 第二种血小板激活剂对抗血小板药物靶向的激活途径不敏感。 将抗凝凝样品同时引入第一和第二通道。 在两个通道中同时进行血小板聚集的水平。
    • 24. 发明申请
    • Code Reader Performing Coded Image Decoding Using Non-Dedicated Decode Processor
    • 代码读取器使用非专用解码处理器执行编码图像解码
    • US20070154092A1
    • 2007-07-05
    • US11681783
    • 2007-03-04
    • Dennis DurbinJon Rasmussen
    • Dennis DurbinJon Rasmussen
    • G06K9/18
    • G06K7/1491G06K7/14
    • A coded image capture and decoding system includes an image capture unit and a host unit which operate to capture image data, generate a plurality of coded images, and, thereafter, to decode the plurality of coded images with a non-dedicated host processing circuitry. The system comprises an image capture unit and a host unit which may be installed together or separately in one or more physical devices. The image capture unit includes an image processor, an image buffer, an optical unit, an image buffer and an interface module. The host unit includes a host processor, conventional hardware and software functions, and an interface module. During a capture cycle, the image capture unit repeatedly captures images from a coded target. When the capture cycle is complete, the image capture unit attempts to interrupt the host unit. The host unit responds to the interrupt when it is available, receives the plurality of coded images over a communication link, and performs decode processing of the coded images. A proximity detector and proximity screening rules may be employed within the image capture unit in an attempt to prevent non-code images from being delivered to the host processor. The host processor may also operate on a composite image and/or parallel process the plurality of coded images to achieve a valid decode.
    • 编码图像捕获和解码系统包括图像捕获单元和主机单元,其操作以捕获图像数据,生成多个编码图像,然后用非专用主机处理电路对多个编码图像进行解码。 该系统包括图像捕获单元和可以一起安装在一个或多个物理设备中的主机单元。 图像捕获单元包括图像处理器,图像缓冲器,光学单元,图像缓冲器和接口模块。 主机单元包括主处理器,常规硬件和软件功能以及接口模块。 在捕获周期期间,图像捕获单元重复地从编码目标捕获图像。 捕获周期完成后,图像捕获单元会尝试中断主机。 主机单元在可用时响应中断,通过通信链路接收多个编码图像,并对编码图像进行解码处理。 可以在图像捕获单元内采用接近检测器和接近度筛选规则,以试图防止非码图像被传送到主机处理器。 主机处理器还可以对合成图像进行操作和/或并行处理多个编码图像以实现有效的解码。
    • 27. 发明申请
    • Controlled platelet activation to monitor therapy of ADP antagonists
    • 控制血小板活化以监测ADP拮抗剂的治疗
    • US20050031616A1
    • 2005-02-10
    • US10886155
    • 2004-07-06
    • Barry CollerDennis Durbin
    • Barry CollerDennis Durbin
    • A61K31/557A61K39/395A61K49/00C12Q20060101C12Q1/00G01N33/53G01N33/567G01N33/86
    • G01N33/86
    • A method is provided of determining whether an individual has reduced ability to form platelet thrombi due to inhibition of platelet activation initiation, signal transduction and/or GPIIb/IIIa blockade. A blood sample is obtained from the individual being assessed. The blood sample is mixed in combination with 1) an anticoagulant; 2) sufficient buffer to maintain the pH and salt concentration of the anticoagulated blood within a range suitable for platelet aggregation; 3) a platelet GPIIb/IIIa receptor ligand immobilized on a solid surface; 4) one or more agents to enhance a signal transduction pathway and 5) a receptor activator. The combination is incubated under conditions for agglutinating particles. Platelet-mediated agglutination is assessed in the agitated mixture. The absence of agglutination indicates that the individual has a reduced ability to form platelet thrombi.
    • 提供一种确定个体是否由于抑制血小板活化起始,信号转导和/或GPIIb / IIIa阻断而形成血小板血栓形成能力降低的方法。 从被评估的个体获得血液样本。 血液样品与1)抗凝剂混合; 2)足够的缓冲液将抗凝血液的pH和盐浓度保持在适合血小板聚集的范围内; 3)固定在固体表面上的血小板GPIIb / IIIa受体配体; 4)增强信号转导途径的一种或多种药物和5)受体激活剂。 将该组合在凝集颗粒的条件下孵育。 在搅拌的混合物中评估血小板介导的凝集。 没有凝集表明个体具有降低形成血小板血栓的能力。